Loading…

Flavivirus DNA vaccines: current status and potential

The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephali...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the New York Academy of Sciences 2001-12, Vol.951 (1), p.272-285
Main Authors: Chang, G J, Davis, B S, Hunt, A R, Holmes, D A, Kuno, G
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753
container_end_page 285
container_issue 1
container_start_page 272
container_title Annals of the New York Academy of Sciences
container_volume 951
creator Chang, G J
Davis, B S
Hunt, A R
Holmes, D A
Kuno, G
description The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephalitis, dengue serotypes 1 and 2, Murray Valley encephalitis, Japanese encephalitis, and West Nile viruses. However, very little is known about the factors affecting its efficacy. Recently, we demonstrated that a single intramuscular immunization of DNA vaccine of Japanese encephalitis and West Nile viruses protected mice and horses from virus challenge. Administration of these recombinant plasmid vectors resulted in endogenous expression and secretion of extracellular virus-like particles that correlated well with the induction of protective immunity. These results provided evidence that the virus-like particles composed of premembrane/membrane and envelope proteins are essential for eliciting immune responses similar to those induced by live, attenuated virus vaccines. The biosynthesis and protein processing of premembrane/membrane and envelope proteins that preserve the native conformation and glycosylation profiles identical to virion proteins could be determined by the effectiveness of the transmembrane signal sequence located at the amino-terminus of premembrane protein. The use of DNA vaccines in multivalent and/or combination vaccines designed to immunize against multiple flaviviruses is also a promising area of development.
doi_str_mv 10.1111/j.1749-6632.2001.tb02703.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72404770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72404770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753</originalsourceid><addsrcrecordid>eNpFkM1OwzAQhC0EoqXwCijiwC3B65_Y6a1qKSBVcIGz5biOlCpNiu1U5e1x1Aj2stLOzK72Q-gBcAaxnnYZCFakeU5JRjCGLJSYCEyz0wWa_kmXaIqxEKksCJ2gG-930UokE9doAiAKISSbIr5u9LE-1q73yep9kRy1MXVr_TwxvXO2DYkPOkRRt9vk0IU4qXVzi64q3Xh7N_YZ-lo_fy5f083Hy9tysUkN4TKkghmKDeSxDOOFFNbkHAPkFaEEJKOyAqpLmleV5GWhK2YBl5yDjIat4HSGHs97D6777q0Pal97Y5tGt7brvRKEYSbi6zM0PxuN67x3tlIHV--1-1GA1QBN7dRARg1k1ABNjdDUKYbvxyt9ubfb_-hIif4Cln9n7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72404770</pqid></control><display><type>article</type><title>Flavivirus DNA vaccines: current status and potential</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Chang, G J ; Davis, B S ; Hunt, A R ; Holmes, D A ; Kuno, G</creator><creatorcontrib>Chang, G J ; Davis, B S ; Hunt, A R ; Holmes, D A ; Kuno, G</creatorcontrib><description>The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephalitis, dengue serotypes 1 and 2, Murray Valley encephalitis, Japanese encephalitis, and West Nile viruses. However, very little is known about the factors affecting its efficacy. Recently, we demonstrated that a single intramuscular immunization of DNA vaccine of Japanese encephalitis and West Nile viruses protected mice and horses from virus challenge. Administration of these recombinant plasmid vectors resulted in endogenous expression and secretion of extracellular virus-like particles that correlated well with the induction of protective immunity. These results provided evidence that the virus-like particles composed of premembrane/membrane and envelope proteins are essential for eliciting immune responses similar to those induced by live, attenuated virus vaccines. The biosynthesis and protein processing of premembrane/membrane and envelope proteins that preserve the native conformation and glycosylation profiles identical to virion proteins could be determined by the effectiveness of the transmembrane signal sequence located at the amino-terminus of premembrane protein. The use of DNA vaccines in multivalent and/or combination vaccines designed to immunize against multiple flaviviruses is also a promising area of development.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1111/j.1749-6632.2001.tb02703.x</identifier><identifier>PMID: 11797784</identifier><language>eng</language><publisher>United States</publisher><subject>Amino Acid Sequence ; Animals ; Flavivirus - genetics ; Flavivirus Infections - prevention &amp; control ; Gene Expression Regulation, Viral ; Humans ; Mice ; Molecular Sequence Data ; Vaccines, DNA ; West Nile Fever - prevention &amp; control</subject><ispartof>Annals of the New York Academy of Sciences, 2001-12, Vol.951 (1), p.272-285</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11797784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, G J</creatorcontrib><creatorcontrib>Davis, B S</creatorcontrib><creatorcontrib>Hunt, A R</creatorcontrib><creatorcontrib>Holmes, D A</creatorcontrib><creatorcontrib>Kuno, G</creatorcontrib><title>Flavivirus DNA vaccines: current status and potential</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephalitis, dengue serotypes 1 and 2, Murray Valley encephalitis, Japanese encephalitis, and West Nile viruses. However, very little is known about the factors affecting its efficacy. Recently, we demonstrated that a single intramuscular immunization of DNA vaccine of Japanese encephalitis and West Nile viruses protected mice and horses from virus challenge. Administration of these recombinant plasmid vectors resulted in endogenous expression and secretion of extracellular virus-like particles that correlated well with the induction of protective immunity. These results provided evidence that the virus-like particles composed of premembrane/membrane and envelope proteins are essential for eliciting immune responses similar to those induced by live, attenuated virus vaccines. The biosynthesis and protein processing of premembrane/membrane and envelope proteins that preserve the native conformation and glycosylation profiles identical to virion proteins could be determined by the effectiveness of the transmembrane signal sequence located at the amino-terminus of premembrane protein. The use of DNA vaccines in multivalent and/or combination vaccines designed to immunize against multiple flaviviruses is also a promising area of development.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Flavivirus - genetics</subject><subject>Flavivirus Infections - prevention &amp; control</subject><subject>Gene Expression Regulation, Viral</subject><subject>Humans</subject><subject>Mice</subject><subject>Molecular Sequence Data</subject><subject>Vaccines, DNA</subject><subject>West Nile Fever - prevention &amp; control</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkM1OwzAQhC0EoqXwCijiwC3B65_Y6a1qKSBVcIGz5biOlCpNiu1U5e1x1Aj2stLOzK72Q-gBcAaxnnYZCFakeU5JRjCGLJSYCEyz0wWa_kmXaIqxEKksCJ2gG-930UokE9doAiAKISSbIr5u9LE-1q73yep9kRy1MXVr_TwxvXO2DYkPOkRRt9vk0IU4qXVzi64q3Xh7N_YZ-lo_fy5f083Hy9tysUkN4TKkghmKDeSxDOOFFNbkHAPkFaEEJKOyAqpLmleV5GWhK2YBl5yDjIat4HSGHs97D6777q0Pal97Y5tGt7brvRKEYSbi6zM0PxuN67x3tlIHV--1-1GA1QBN7dRARg1k1ABNjdDUKYbvxyt9ubfb_-hIif4Cln9n7A</recordid><startdate>200112</startdate><enddate>200112</enddate><creator>Chang, G J</creator><creator>Davis, B S</creator><creator>Hunt, A R</creator><creator>Holmes, D A</creator><creator>Kuno, G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200112</creationdate><title>Flavivirus DNA vaccines: current status and potential</title><author>Chang, G J ; Davis, B S ; Hunt, A R ; Holmes, D A ; Kuno, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Flavivirus - genetics</topic><topic>Flavivirus Infections - prevention &amp; control</topic><topic>Gene Expression Regulation, Viral</topic><topic>Humans</topic><topic>Mice</topic><topic>Molecular Sequence Data</topic><topic>Vaccines, DNA</topic><topic>West Nile Fever - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, G J</creatorcontrib><creatorcontrib>Davis, B S</creatorcontrib><creatorcontrib>Hunt, A R</creatorcontrib><creatorcontrib>Holmes, D A</creatorcontrib><creatorcontrib>Kuno, G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, G J</au><au>Davis, B S</au><au>Hunt, A R</au><au>Holmes, D A</au><au>Kuno, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Flavivirus DNA vaccines: current status and potential</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>2001-12</date><risdate>2001</risdate><volume>951</volume><issue>1</issue><spage>272</spage><epage>285</epage><pages>272-285</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>The use of DNA-based vaccines is a novel and promising immunization approach for the development of flavivirus vaccines. This approach has been attempted in vaccine development for various virus species, including St. Louis encephalitis, Russian spring-summer encephalitis, Central European encephalitis, dengue serotypes 1 and 2, Murray Valley encephalitis, Japanese encephalitis, and West Nile viruses. However, very little is known about the factors affecting its efficacy. Recently, we demonstrated that a single intramuscular immunization of DNA vaccine of Japanese encephalitis and West Nile viruses protected mice and horses from virus challenge. Administration of these recombinant plasmid vectors resulted in endogenous expression and secretion of extracellular virus-like particles that correlated well with the induction of protective immunity. These results provided evidence that the virus-like particles composed of premembrane/membrane and envelope proteins are essential for eliciting immune responses similar to those induced by live, attenuated virus vaccines. The biosynthesis and protein processing of premembrane/membrane and envelope proteins that preserve the native conformation and glycosylation profiles identical to virion proteins could be determined by the effectiveness of the transmembrane signal sequence located at the amino-terminus of premembrane protein. The use of DNA vaccines in multivalent and/or combination vaccines designed to immunize against multiple flaviviruses is also a promising area of development.</abstract><cop>United States</cop><pmid>11797784</pmid><doi>10.1111/j.1749-6632.2001.tb02703.x</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0077-8923
ispartof Annals of the New York Academy of Sciences, 2001-12, Vol.951 (1), p.272-285
issn 0077-8923
1749-6632
language eng
recordid cdi_proquest_miscellaneous_72404770
source Wiley-Blackwell Read & Publish Collection
subjects Amino Acid Sequence
Animals
Flavivirus - genetics
Flavivirus Infections - prevention & control
Gene Expression Regulation, Viral
Humans
Mice
Molecular Sequence Data
Vaccines, DNA
West Nile Fever - prevention & control
title Flavivirus DNA vaccines: current status and potential
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T10%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Flavivirus%20DNA%20vaccines:%20current%20status%20and%20potential&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Chang,%20G%20J&rft.date=2001-12&rft.volume=951&rft.issue=1&rft.spage=272&rft.epage=285&rft.pages=272-285&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1111/j.1749-6632.2001.tb02703.x&rft_dat=%3Cproquest_cross%3E72404770%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c258t-74c30c16666c45987ec650116f23218438f13ab36ff85b9af4e10b5518f23d753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72404770&rft_id=info:pmid/11797784&rfr_iscdi=true